Themis Medicare informs about outcome of board meeting

28 Jul 2022 Evaluate

Themis Medicare has informed that the Board of Directors at its meeting held today, considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30lh June, 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2022 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

84.22 0.20 (0.24%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×